These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30698448)

  • 21. Carboxymethyl dextran-based hypoxia-responsive nanoparticles for doxorubicin delivery.
    Son S; Rao NV; Ko H; Shin S; Jeon J; Han HS; Nguyen VQ; Thambi T; Suh YD; Park JH
    Int J Biol Macromol; 2018 Apr; 110():399-405. PubMed ID: 29133095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
    Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
    Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HER2 scFv-nCytc-Modified Lipid-Encapsulated Oxygen Nanobubbles Prepared with Bulk Nanobubble Water for Inducing Apoptosis and Improving Photodynamic Therapy.
    Tian J; Wan S; Tian J; Liu L; Xia J; Hu Y; Yang Z; Zhao H; Wang H; Guo Y; Guo J
    Small; 2023 Jun; 19(23):e2206091. PubMed ID: 36855335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alleviating tumor hypoxia with perfluorocarbon-based oxygen carriers.
    Krafft MP
    Curr Opin Pharmacol; 2020 Aug; 53():117-125. PubMed ID: 32979727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and in vitro characterization of chitosan nanobubbles as theranostic agents.
    Cavalli R; Argenziano M; Vigna E; Giustetto P; Torres E; Aime S; Terreno E
    Colloids Surf B Biointerfaces; 2015 May; 129():39-46. PubMed ID: 25819364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
    Sun X; Zhang G; Wu Z
    Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen nanobubbles revert hypoxia by methylation programming.
    Bhandari PN; Cui Y; Elzey BD; Goergen CJ; Long CM; Irudayaraj J
    Sci Rep; 2017 Aug; 7(1):9268. PubMed ID: 28839175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives.
    Thambi T; Park JH; Lee DS
    Chem Commun (Camb); 2016 Jun; 52(55):8492-500. PubMed ID: 27225824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein Shell-Encapsulated Pt Clusters as Continuous O
    Li Y; Jian X; Zhou S; Lu Y; Zhao C; Gao Z; Song YY
    ACS Appl Mater Interfaces; 2019 May; 11(19):17215-17225. PubMed ID: 31007010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicolor nanobubbles for FRET/ultrasound dual-modal contrast imaging.
    Zhang X; Liu R; Dai Z
    Nanoscale; 2018 Nov; 10(43):20347-20353. PubMed ID: 30375631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent visual and acoustic tracking of passive and active delivery of nanobubbles to tumors.
    Pellow C; Abenojar EC; Exner AA; Zheng G; Goertz DE
    Theranostics; 2020; 10(25):11690-11706. PubMed ID: 33052241
    [No Abstract]   [Full Text] [Related]  

  • 32. Nanocarriers responsive to a hypoxia gradient facilitate enhanced tumor penetration and improved anti-tumor efficacy.
    Zhen J; Tian S; Liu Q; Zheng C; Zhang Z; Ding Y; An Y; Liu Y; Shi L
    Biomater Sci; 2019 Jul; 7(7):2986-2995. PubMed ID: 31106796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfluoropentane-filled chitosan poly-acrylic acid nanobubbles with high stability for long-term ultrasound imaging
    Gao X; Guo D; Mao X; Shan X; He X; Yu C
    Nanoscale; 2021 Mar; 13(10):5333-5343. PubMed ID: 33659972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-Assembly Assisted Fabrication of Dextran-Based Nanohydrogels with Reduction-Cleavable Junctions for Applications as Efficient Drug Delivery Systems.
    Wang H; Dai T; Zhou S; Huang X; Li S; Sun K; Zhou G; Dou H
    Sci Rep; 2017 Jan; 7():40011. PubMed ID: 28071743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight.
    Chen N; Collier MA; Gallovic MD; Collins GC; Sanchez CC; Fernandes EQ; Bachelder EM; Ainslie KM
    Int J Pharm; 2016 Oct; 512(1):147-157. PubMed ID: 27543351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
    Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
    Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
    Braga CB; Perli G; Becher TB; Ornelas C
    Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery.
    Meenach SA; Kim YJ; Kauffman KJ; Kanthamneni N; Bachelder EM; Ainslie KM
    Mol Pharm; 2012 Feb; 9(2):290-8. PubMed ID: 22149217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.
    Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D
    Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering of Biocompatible pH-Responsive Nanovehicles from Acetalated Cyclodextrins as Effective Delivery Systems for Tumor Therapy.
    Zhang D; Wei Y; Chen K; Gong H; Han S; Guo J; Li X; Zhang J
    J Biomed Nanotechnol; 2015 Jun; 11(6):923-41. PubMed ID: 26353583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.